These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 4398226)
21. [Clinical trial using the beta receptor blockader Visken]. Szám I; Holló J Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675 [No Abstract] [Full Text] [Related]
22. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol. Dagenais GR; Pitt B; Ross RS Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511 [No Abstract] [Full Text] [Related]
23. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris. Sharma B; Taylor SH Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578 [No Abstract] [Full Text] [Related]
24. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate. Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736 [No Abstract] [Full Text] [Related]
25. Trasicor in angina pectoris: a double-blind trial. Wilson DF; Watson OF; Peel JS; Turner AS Br Med J; 1969 Apr; 2(5650):155-7. PubMed ID: 4976123 [TBL] [Abstract][Full Text] [Related]
26. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris]. Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507 [No Abstract] [Full Text] [Related]
27. Practolol in patients with angina pectoris. Alderman EL; Davis RO; Friedman JP; Graham AF; Matlof HJ; Harrison DC Clin Pharmacol Ther; 1973; 14(2):175-81. PubMed ID: 4144425 [No Abstract] [Full Text] [Related]
28. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal. Wasserman AJ; Proctor JD; Allen FJ; Kemp VE J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785 [No Abstract] [Full Text] [Related]
29. [Use of LB-46 in angina pectoris and cardiac arrhythmias]. Maranhão MF; da Cunha GP; Rojas RI Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346 [No Abstract] [Full Text] [Related]
30. [Treatment of angina pectoris with Trasicor (CIBA 39089-Ba)]. Lorenzen J Nord Med; 1970 Jun; 83(25):783-5. PubMed ID: 4393479 [No Abstract] [Full Text] [Related]
31. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis]. Schaller K Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819 [No Abstract] [Full Text] [Related]
32. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Thadani U; Sharma B; Meeran MK; Majid PA; Whitaker W; Taylor SH Br Med J; 1973 Jan; 1(5846):138-42. PubMed ID: 4145234 [TBL] [Abstract][Full Text] [Related]
33. Sotalol in the treatment of angina pectoris. A double-blind cross-over study. Kentala E; Pyörälä K; Frick MH Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692 [No Abstract] [Full Text] [Related]
34. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris. Coltart DJ; Hamer J Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080 [No Abstract] [Full Text] [Related]
35. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients]. Saner R Therapie; 1970; 25(2):393-501. PubMed ID: 4403159 [No Abstract] [Full Text] [Related]